Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

NCT03209401 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Solid Tumor, Adult
Homologous Recombination Deficiency

Interventions

DRUG: Niraparib
DRUG: Carboplatin

Sponsor

Georgetown University

Collaborators

[object Object]
[object Object]